Here’s whether Cytokinetics Inc. (CYTK) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+2.81% over 10 days); strong 1-year return of +116.4%; 3-month momentum positive (+23.6%). Concerns: declining volume on rally — weak conviction (0.67x 30d avg). Currently 8.6% off its 52-week high. Score: +5/7.
CYTK is in a confirmed uptrend, trading above both its 50-day ($78.33) and 200-day ($67.46) moving averages. An RSI of 33.6 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +116.4% compares to +16.5% for SPY (beat the market by 99.9%).
$10,000 invested 1 year ago→ $21,640 today
vs. S&P 500 (SPY) — same period beat market by 99.9%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($67.46)
✓Above 50-day MA ($78.33)
✓RSI(14) neutral zone (30–70) — currently 33.6
✓Positive return (+116.4%)
✓Within 10% of period high (−8.6%)
Period Range $80.74
$32.89$88.31
RSI (14) 33.6
0 · OversoldOverbought · 100
Key Metrics
Price$80.74
Period Return+116.4%
Period High$88.31
Period Low$32.89
Drawdown−8.6%
MA-50$78.33
MA-200$67.46
RSI (14)33.6
Avg Volume (30d)2.2M
vs. SPYbeat by 99.9%
Return Rank#81 of 999
Trend Signals
Price is above the 200-day moving average ($67.46)